Opportunity Information: Apply for W81XWH 10 NFRP EHDA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis Exploration Hypothesis Development Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Mar 2, 2010 and posted on Mar 2, 2010.
  • Applicants must submit their applications by May 20, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $750,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 5 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 10 NFRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The DoD Neurofibromatosis Exploration - Hypothesis Development Award (EHDA) is a Department of Defense funding opportunity run through the Neurofibromatosis Research Program (NFRP) under the U.S. Army Medical Research and Acquisition Activity (USAMRAA). It is designed to help researchers take early, exploratory steps on new ideas in neurofibromatosis and/or schwannomatosis, especially ideas that are innovative, high-risk, and potentially high-reward. The award is meant to generate the kind of initial findings that either justify building a brand-new hypothesis or establish early guiding principles for an unconventional hypothesis. A core theme of the mechanism is giving investigators room to follow promising, even unexpected, observations rather than requiring a fully mature research plan backed by extensive preliminary results.

A key expectation is that the Principal Investigator clearly explains what makes the proposed work novel and why it represents a genuinely innovative direction for the field. Preliminary data can be included and may strengthen an application, but it is not required, which signals that the program is intentionally set up to support early-stage concept testing rather than later-stage validation. Historically, the program had received 46 applications since it began in FY08, with 13 recommended for funding, underscoring that it is competitive and selective.

Because this mechanism is intended for preliminary investigations, it places strict limits on human subjects research. Projects involving human subjects or human specimens are generally not supported unless they qualify as exempt under 32 CFR 219.101(b) or are eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110. Applications that propose human research that does not meet exempt or expedited criteria are not simply scored poorly; they are administratively withdrawn. Researchers who want to run a clinical trial are directed to use a separate Clinical Trial Award mechanism instead, meaning the EHDA is not the right vehicle for trial-based clinical studies.

For FY10, the program explicitly encouraged proposals aligned with pressing needs in the NF community. Priority themes included complications associated with high mortality, such as tumors (neoplasms) and cerebrovascular abnormalities, as well as high-morbidity complications like skeletal problems, learning deficits, hormone-related effects, and pain. The program also encouraged work that improves the tools needed for future clinical trials, including refining and standardizing imaging methods, molecular and cellular markers, and quality-of-life measures. Another emphasized area was translational research, particularly development or preclinical testing of therapeutic agents aimed at treating NF.

Administratively, this opportunity was posted March 2, 2010, and closed May 20, 2010 (archived June 19, 2010). It used grant and cooperative agreement instruments under a science and technology research and development category, with an estimated total funding level of $750,000 and an expectation of about five awards. There was no cost-sharing requirement, and eligibility was described as unrestricted (open to any entity type, subject to any clarifications in the full announcement). The funding opportunity number was W81XWH-10-NFRP-EHDA and the CFDA number listed was 12.420 (Military Medical Research and Development). Contact points were provided through the CDMRP help resources for assistance with accessing the announcement and with electronic submission.

FAQs: DoD Neurofibromatosis Exploration - Hypothesis Development Award (EHDA)

What is the DoD Neurofibromatosis Exploration - Hypothesis Development Award (EHDA)?

The EHDA is a Department of Defense funding opportunity offered through the Neurofibromatosis Research Program (NFRP) and managed under the U.S. Army Medical Research and Acquisition Activity (USAMRAA). It is intended to support early, exploratory research in neurofibromatosis and/or schwannomatosis.

What is the main purpose of the EHDA mechanism?

The EHDA is designed to help researchers take initial steps on new, innovative ideas, particularly those that are high-risk and potentially high-reward. The goal is to generate early findings that either justify forming a brand-new hypothesis or provide early guiding principles for an unconventional hypothesis.

What types of projects are a good fit for this award?

Projects that test early-stage concepts, explore promising new directions, and allow investigators to follow unexpected or emerging observations are a good fit. The mechanism is built for concept testing rather than mature, later-stage validation efforts.

How important is innovation and novelty in the application?

A key expectation is that the Principal Investigator clearly explains what makes the work novel and why it represents a genuinely innovative direction for the neurofibromatosis and/or schwannomatosis field.

Is preliminary data required to apply?

No. Preliminary data may be included and could strengthen an application, but it is not required. This reflects the program intent to support early-stage exploration rather than proposals that already have extensive supporting results.

How competitive is the EHDA?

Historically, since the mechanism began in FY08, 46 applications were received and 13 were recommended for funding. This indicates the award has been competitive and selective.

Are human subjects studies allowed under the EHDA?

Human subjects research and research involving human specimens are generally not supported unless the work qualifies as exempt under 32 CFR 219.101(b) or is eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110.

What happens if an application proposes human subjects research that is not exempt or eligible for expedited review?

Applications proposing human research that does not meet the exempt or expedited criteria are administratively withdrawn (not merely scored poorly).

Can EHDA funds be used to run a clinical trial?

No. Researchers intending to conduct a clinical trial are directed to use a separate Clinical Trial Award mechanism. The EHDA is not intended for trial-based clinical studies.

What research priorities or themes were encouraged for FY10?

For FY10, the program encouraged proposals addressing pressing needs in the NF community, including complications associated with high mortality (such as tumors/neoplasms and cerebrovascular abnormalities) and high-morbidity complications (such as skeletal problems, learning deficits, hormone-related effects, and pain).

Did the program encourage development of tools for future clinical trials?

Yes. The program encouraged work to improve tools needed for future clinical trials, including refining and standardizing imaging methods, molecular and cellular markers, and quality-of-life measures.

Was translational research encouraged?

Yes. Translational research was emphasized, including the development or preclinical testing of therapeutic agents aimed at treating neurofibromatosis.

Who runs or manages this funding opportunity?

The opportunity is part of the DoD Neurofibromatosis Research Program (NFRP) and is administered through USAMRAA.

What was the posting and closing timeline for this opportunity?

The opportunity was posted on March 2, 2010, and closed on May 20, 2010. It was archived on June 19, 2010.

What kind of funding instruments were used?

The opportunity used grant and cooperative agreement instruments under a science and technology research and development category.

What was the estimated total funding amount and the expected number of awards?

The estimated total funding level was $750,000, with an expectation of about five awards.

Was cost sharing required?

No cost-sharing requirement was listed for this opportunity.

Who was eligible to apply?

Eligibility was described as unrestricted (open to any entity type), subject to any clarifications included in the full announcement.

What is the funding opportunity number for the EHDA?

The funding opportunity number was W81XWH-10-NFRP-EHDA.

What CFDA number was associated with this opportunity?

The CFDA number listed was 12.420, Military Medical Research and Development.

Where could applicants get help with the announcement or electronic submission?

Contact points were provided through CDMRP help resources for assistance with accessing the announcement and with electronic submission.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award

Previous opportunity: DoD Neurofibromatosis New Investigator Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 10 NFRP EHDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 10 NFRP EHDA) also looked into and applied for these:

Funding Opportunity
DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award Apply for W81XWH 10 TSCRP EHDA

Funding Number: W81XWH 10 TSCRP EHDA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Tuberous Sclerosis Complex Career Transition Award Apply for W81XWH 10 TSCRP CARTA

Funding Number: W81XWH 10 TSCRP CARTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Laboratory Clinical Transition Award Apply for W81XWH 10 PCRP LCTA

Funding Number: W81XWH 10 PCRP LCTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Population Based Research Award Apply for W81XWH 10 PCRP PBRA

Funding Number: W81XWH 10 PCRP PBRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Office Wide Broad Agency Announcement Microsystems Technology Office Apply for DARPA BAA 10 35

Funding Number: DARPA BAA 10 35
Agency: DARPA Microsystems Technology Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Research in Innovative Approaches to Fusion Energy Sciences Apply for DE FOA 0000286

Funding Number: DE FOA 0000286
Agency: Chicago Service Center
Category: Science and Technology and other Research and Development
Funding Amount: $1,700,000
George Mason University Center for Infrastructure Protection Apply for 2010 CIP 06

Funding Number: 2010 CIP 06
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Hawaii, Hawaii Open Supercomputing Center Apply for 2010 CIP 08

Funding Number: 2010 CIP 08
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Kentucky Firefighter Gear Safety Research Program Apply for 2010 CIP 09

Funding Number: 2010 CIP 09
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Maryland Baltimore County Maryland Center of Excellence for Terahertz Science and Application Apply for 2010 CIP 10

Funding Number: 2010 CIP 10
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Rhode Island Rhode Island Consortium for Nanoscience and Nanotechnology Apply for 2010 CIP 11

Funding Number: 2010 CIP 11
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Agile Delivery of Electrical Power Technology (ADEPT) Apply for DE FOA 0000288

Funding Number: DE FOA 0000288
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
University at Albany (SUNY) New York Center for National Competitiveness in Nanoscale Characterization at the College of Nanoscale Science and Engineering (CNSE) Apply for 2010 CIP 05

Funding Number: 2010 CIP 05
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Building Energy Efficiency Through Innovative Thermodevices (BEETIT) Apply for DE FOA 0000289

Funding Number: DE FOA 0000289
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
Gridscale Rampable Intermittently Dispatchable Storage (GRIDS) Apply for DE FOA 0000290

Funding Number: DE FOA 0000290
Agency: Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $10,000,000
North Dakota State University Advanced Nanomaterials Research Facility Apply for 2010 CIP 04

Funding Number: 2010 CIP 04
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Alabama Interdisciplinary Science and Engineering Teaching and Research Corridor Apply for 2010 CIP 01

Funding Number: 2010 CIP 01
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
University of Mississippi Medical Center The Mississippi Biotechnology Research Park Apply for 2010 CIP 02

Funding Number: 2010 CIP 02
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Mississippi State University Expansion of the Research, Technology and Economic Development Park Apply for 2010 CIP 03

Funding Number: 2010 CIP 03
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
DoD Prostate Cancer Health Disparity Training Award Apply for W81XWH 10 PCRP HDTA

Funding Number: W81XWH 10 PCRP HDTA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 10 NFRP EHDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.